PRINCIPLES AND PRACTICE OF DIALYSIS
Author: William Henrich, MD, MACP
Publisher: Lippincott Williams & Wilkins
Publication Date: 2009
Publisher: Lippincott Williams & Wilkins
Publication Date: 2009
ISBN 10: 0781781639
ISBN 13: 9780781781633
Edition: 4th
ISBN 13: 9780781781633
Edition: 4th
Description:
This book is an evidence-based review of the practical challenges of dealing with patients receiving dialysis. The first section covers technical and procedural considerations such as choosing the hemodialysis membrane and choosing the best dialysis option. The second section covers clinical considerations such as infection and the treatment of specific renal disease complications. The book includes numerous illustrations and tables and drug charts for dialysis patients. This edition's current outcomes chapter has been expanded to include patient depression and improving quality of care. New chapters cover dialysis in the ICU, valvular heart disease, and pre-emptive renal transplantation.
Table of Contents
Front Matter
Choice of the Hemodialysis Membrane
Reuse of Hemodialysis Membranes in Chronic Dialysis Therapy
- HISTORICAL INTRODUCTION
- TYPES OF REUSE
- THE NUMBER OF REUSE
- BLOOD CELLULOSIC INTERACTIONS
- SAFETY
- POTENTIAL LONG-TERM HAZARDS OF DIALYZER REUSE
- INFECTION RISK
- TOXICITY OF LONG-TERM ACCUMULATIVE EXPOSURE TO DIALYZER REUSE
- MORTALITY
- REPROCESSING TECHNIQUE
- IDENTIFICATION
- RINSING
- CLEANING
- TEST OF DIALYZER PERFORMANCE
- TEST OF FIBER BUNDLE VOLUME
- DISINFECTANT AND STERILIZATION
- INSPECTION
- SUMMARY
- REFERENCES
Dialysate Composition in Hemodialysis and Peritoneal Dialysis
Hemodialysis Vascular Access
Anticoagulation Strategies During Hemodialysis Procedures
Approach to Hemodialysis Kinetic Modeling
- HISTORICAL PERSPECTIVE
- UREA, A MARKER FOR CLEARANCE AND PROTEIN CATABOLISM
- FACTORS THAT DETERMINE THE REQUIREMENT FOR DIALYSIS
- TARGETING THE AMOUNT OF DIALYSIS
- SINGLE-COMPARTMENT KINETIC MODELING
- MULTIPLE-COMPARTMENT KINETIC MODELING
- DIALYSATE METHODS
- THE DIALYSIS SCHEDULE: MORE FREQUENT IS MORE EFFICIENT
- SIMPLIFIED APPROACHES TO QUANTIFYING DIALYSIS
- PRACTICE GUIDELINES AND STANDARDS
- PITFALLS OF UREA MODELING
- SUMMARY
- REFERENCES
Choosing the Best Dialysis Option in the Patient with End-Stage Kidney Disease
Hemodialysis Adequacy and the Timing of Dialysis Initiation
High-Flux and High-Efficiency Procedures
- DEFINITION OF HIGH-EFFICIENCY AND HIGH-FLUX DIALYSIS
- TECHNICAL REQUIREMENTS FOR HIGH-EFFICIENCY AND HIGH-FLUX TREATMENTS
- CLINICAL APPLICATIONS OF HIGH-EFFICIENCY AND HIGH-FLUX THERAPIES
- SHORT HEMODIALYSIS
- LONG-TERM SURVIVAL OF PATIENTS ON HIGH-EFFICIENCY AND HIGH-FLUX DIALYSIS
- CONCLUSION
- ACKNOWLEDGMENTS
- REFERENCES
Long and Daily Hemodialysis
Prescribing Drugs for Dialysis Patients
Continuous Dialysis Therapeutic Techniques
Choosing the Best Dialysis Option in Patients with Acute Renal Failure and in the Intensive Care Unit
- HOW IS THE APPLICATION OF EXTRACORPOREAL BLOOD PURIFICATION DIFFERENT IN THE INTENSIVE CARE UNIT?
- EXTRACORPOREAL BLOOD PURIFICATION: CURRENT TECHNOLOGY, HYBRID CIRCUITS, AND EMERGING MODALITIES
- SPECIAL CIRCUMSTANCES
- ROLE OF NEPHROLOGISTS IN THE INTENSIVE CARE UNIT
- CONCLUSION
- ACKNOWLEDGMENTS
- REFERENCES
Adequacy of Peritoneal Dialysis
- WHAT YARDSTICK FOR ADEQUACY OF DIALYSIS SHOULD WE USE?
- RECOMMENDED ACCEPTABLE TOTAL SOLUTE CLEARANCE TARGETS FOR PERITONEAL DIALYSIS
- IMPORTANCE OF RESIDUAL RENAL FUNCTION
- IMPACT OF NUTRITIONAL STATUS ON PATIENT OUTCOME
- MEASUREMENTS OF NUTRITIONAL STATUS
- MAJOR DETERMINANTS OF TOTAL SOLUTE CLEARANCE
- SPECIAL CONSIDERATIONS
- VOLUME AND BLOOD PRESSURE CONTROL ISSUES
- HOW TO MONITOR DIALYSIS DOSE?
- NONCOMPLIANCE
- PRESCRIPTION DIALYSIS
- SUMMARY
- REFERENCES
Causes, Diagnosis, and Treatment of Peritoneal Membrane Failure
- SOLUTE AND FLUID TRANSPORT IN PERITONEAL DIALYSIS
- EVALUATION OF PERITONEAL MEMBRANE FUNCTION
- DIAGNOSTIC APPROACH, DIFFERENTIAL DIAGNOSIS, AND TREATMENT OF THE PATIENT WITH ULTRAFILTRATION FAILURE
- FLUID OVERLOAD WITHOUT ULTRAFILTRATION FAILURE
- FLUID OVERLOAD WITH ULTRAFILTRATION FAILURE
- CONCLUSION
- REFERENCES
Hypertension in Dialysis Patients
Left Ventricular Dysfunction and Valvular Heart Disease in Dialysis Patients
Coronary Artery Disease in End-Stage Renal Disease Patients
- PATHOGENESIS OF ATHEROSCLEROSIS IN PATIENTS WITH END-STAGE RENAL DISEASE
- CLINICAL PRESENTATION OF CORONARY ARTERY DISEASE IN PATIENTS WITH END-STAGE RENAL DISEASE
- DIAGNOSIS OF CORONARY ARTERY DISEASE IN PATIENTS WITH END-STAGE RENAL DISEASE
- MANAGEMENT OF CORONAY ARTERY DISEASE IN PATIENTS WITH END-STAGE RENAL DISEASE
- REFERENCES
Hemodynamic Stability and Autonomic Dysfunction in End-Stage Renal Disease
- OVERVIEW OF THE PROBLEM
- VASCULAR REFILLING
- CARDIAC REFILLING AND VENOUS DYSFUNCTION
- SYSTOLIC AND DIASTOLIC FUNCTION OF THE HEART
- ARTERIAL DYSFUNCTION
- AUTONOMIC NEUROPATHY
- THERAPY FOR HEMODYNAMIC INSTABILITY DURING HEMODIALYSIS
- INDIVIDUALIZING THE DIALYSIS PRESCRIPTION
- ACUTE TREATMENT OF HYPOTENSION
- REFERENCES
Oxidant Stress in End-Stage Renal Disease
- DEFINITION OF OXIDANT STRESS
- GENERATION OF REACTIVE OXYGEN SPECIES IN THE BIOLOGIC SYSTEM
- PHYSIOLOGIC ANTIOXIDANT SYSTEM
- PATHOPHYSIOLOGY OF OXIDATIVE STRESS IN DIALYSIS PATIENTS
- BIOMARKERS OF OXIDATIVE STRESS
- ADVANCED GLYCATION END PRODUCTS
- ADVANCED LIPID PEROXIDATION (ATOMIC LAYER EPITAXIES)
- ADVANCED OXIDIZED PROTEIN PRODUCTS
- THE EUROPEAN UREMIC TOXIN WORK GROUP
- CONSEQUENCES OF INCREASED OXIDATIVE STRESS
- OXIDANT STRESS AND ACCELERATED ATHEROSCLEROSIS
- ROLE OF REACTIVE OXYGEN SPECIES IN THE PATHOGENESIS OF β2 MICROGLOBULIN DISEASE
- REACTIVE OXYGEN SPECIES AND THEIR ROLE IN PERITONEAL MEMBRANE FAILURE IN PERITONEAL DIALYSIS PATIENTS
- REACTIVE OXYGEN SPECIES AND THEIR ROLE IN THE PATHOGENESIS OF INFLAMMATION AND CARDIOVASCULAR DISEASE
- ENDOTHELIAL DYSFUNCTION
- CAN DIALYSIS-ASSOCIATED INCREASED OXIDATIVE STRESS BE PREVENTED?
- SUMMARY
- REFERENCES
Low-Grade Persistent Inflammation and Immune Dysfunction in Uremia
Hepatitis and Human Immunodeficiency Virus Infections in End-Stage Renal Disease Patients
- EPIDEMIOLOGY OF HEPATITIS B VIRUS, HEPATITIS C VIRUS, AND HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS IN HEMODIALYSIS PATIENTS
- MORBIDITY AND MORTALITY OF HUMAN IMMUNODEFICIENCY VIRUS, HEPATITIS C VIRUS, AND HEPATITIS B VIRUS INFECTION IN HEMODIALYSIS PATIENTS
- SCREENING AND PREVENTION RECOMMENDATIONS FOR HUMAN IMMUNODEFICIENCY VIRUS, HEPATITIS B VIRUS, AND HEPATITIS C VIRUS IN HEMODIALYSIS PATIENTS
- HEPATITIS C VIRUS SCREENING
- TREATMENT OF HEPATITIS C VIRUS, HEPATITIS B VIRUS, AND HUMAN IMMUNODEFICIENCY VIRUS IN HEMODIALYSIS PATIENTS
- TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS IN HEMODIALYSIS PATIENTS
- INFECTION CONTROL MEASURES IN THE DIALYSIS UNIT
- POSTEXPOSURE PROPHYLAXIS GUIDELINES FOR PATIENTS AND STAFF
- HEPATITIS B VIRUS
- HEPATITIS C VIRUS
- REFERENCES
Endocrine Disease in Dialysis Patients
Gastrointestinal Complications in End-Stage Renal Disease
Renal Osteodystrophy
Acid–Base Considerations in End-Stage Renal Disease
- GENERAL PRINCIPLES
- ACID–BASE HOMEOSTASIS IN PERITONEAL DIALYSIS
- ACID–BASE HOMEOSTASIS IN HEMODIALYSIS
- EFFECTS OF METABOLIC ACIDOSIS ON BONE AND MUSCLE METABOLISM
- EFFECT OF PREDIALYSIS SERUM SERUM [HCO3−] ON MORTALITY
- MANAGEMENT OF PATIENTS WITH LOW SERUM [HCO3−]
- DAILY HEMODIALYSIS
- CONTINUOUS RENAL REPLACEMENT THERAPIES
- ACID–BASE DISORDERS IN PATIENTS WITH END-STAGE RENAL DISEASE
- SUMMARY
- REFERENCES
Dyslipidemia in Dialysis Patients
Malnutrition and Intradialytic Parenteral Nutrition in Patients with End-Stage Renal Disease
Disorders of Hemostasis in Dialysis Patients
Treatment of Anemia in Patients with End-Stage Renal Disease
- ANEMIA OF CHRONIC KIDNEY DISEASE: MAGNITUDE OF THE PROBLEM
- PHYSIOLOGY OF ERYTHROPOIETIN AND ERYTHROPOIESIS
- CLINICAL AND LABORATORY FEATURES
- PATHOPHYSIOLOGY OF THE ANEMIA OF RENAL DISEASE
- THERAPY OF RENAL ANEMIA
- ADVERSE EVENTS OF RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY
- TREATMENT OF ANEMIA
- REFERENCES
Neurologic Complications Associated with Dialysis and Chronic Renal Insufficiency
The Geriatric Dialysis Patient
- DEMOGRAPHIC CHARACTERISTICS OF THE GERIATRIC POPULATION WITH END-STAGE RENAL DISEASE
- INDICATIONS FOR INITIATION OF DIALYSIS
- CHOOSING A KIDNEY REPLACEMENT THERAPY MODALITY
- DIALYSIS TECHNICAL CONSIDERATIONS
- SPECIAL SITUATIONS IN THE ELDERLY DIALYSIS PATIENT
- SPECIAL SITUATIONS IN THE ELDERLY PERITONEAL DIALYSIS PATIENT
- DIALYSIS IN A NURSING HOME SETTING
- ETHICAL ISSUES IN ELDERLY DIALYSIS PATIENTS
- REFERENCES
Dialytic Therapy for Renal Failure in Pandemic Diabetes and Nephropathy
- EPIDEMIOLOGY
- IMPACT OF DIABETES ON PATIENTS AND NATIONAL RESOURCES
- DIABETIC RENAL DISEASE
- PREPARING FOR RENAL REPLACEMENT THERAPY
- HEMODIALYSIS-RELATED COMPLICATIONS
- CONTINUOUS AMBULATORY PERITONEAL DIALYSIS IN DIABETIC PATIENTS
- RENAL TRANSPLANTATION IN PATIENTS WITH DIABETIC NEPHROPATHY
- CONCLUSION
- REFERENCES
Quality of Life and Rehabilitation in Dialysis Patients
- DEFINITION OF QUALITY OF LIFE
- MEASUREMENT OF QUALITY OF LIFE
- QUALITY OF LIFE IN END-STAGE RENAL DISEASE
- IMPACT OF QUALITY OF LIFE
- EARLY REFERRAL
- SLEEP DISTURBANCES
- SOCIAL SUPPORT AND THE QUALITY OF LIFE FOR CAREGIVERS
- ANEMIA
- DEPRESSION
- DEMOGRAPHIC VARIABLES
- HEALTH-RELATED QUALITY OF LIFE
- DIALYSIS-RELATED FACTORS
- NUTRITION AND PHYSICAL ACTIVITY
- CONCLUSION
- REFERENCES
Extracorporeal Treatment of Poisoning and Drug Overdose
- EPIDEMIOLOGY
- GENERAL TREATMENT MEASURES
- EXTRACORPOREAL METHODS OF DETOXIFICATION
- CRITERIA FOR THE USE OF EXTRACORPOREAL TECHNIQUES IN THE TREATMENT OF EXOGENOUS INTOXICATIONS
- ETHYLENE GLYCOL
- METHANOL
- ISOPROPANOL (ISOPROPYL ALCOHOL)
- SALICYLATES
- LITHIUM
- THEOPHYLLINE
- ETHANOL
- ACETAMINOPHEN OVERDOSE
- REFERENCES
Chronic Dialysis in Children
- EPIDEMIOLOGIC ISSUES
- PRINCIPLES OF DIALYSIS IN CHILDREN: PERITONEAL DIALYSIS
- PRINCIPLES OF DIALYSIS IN CHILDREN: HEMODIALYSIS
- DIALYSIS FOR ACUTE RENAL FAILURE IN CHILDREN
- DIALYSIS FOR END-STAGE RENAL DISEASE IN CHILDREN
- CHRONIC PERITONEAL DIALYSIS FOR CHILDREN
- COMPLICATIONS OF CHRONIC PERITONEAL DIALYSIS IN CHILDREN
- CHRONIC HEMODIALYSIS FOR CHILDREN
- METHODS TO PREVENT ULTRAFILTRATION-ASSOCIATED SYMPTOMS
- HEMODIALYSIS FOR NEONATES AND INFANTS
- ADDITIONAL CLINICAL ISSUES IN THE PEDIATRIC DIALYSIS PATIENT
- REFERENCES
Acute Dialysis in Children
Infections in Patients on Peritoneal Dialysis
Preparing Dialysis Patients for Renal Transplantation
Current Outcomes for Dialysis Patients and Improving Quality of Care for Dialysis Patients
- Epidemiologic and Demographic Trends in End-Stage Renal Disease
- Medicare End-Stage Renal Disease Program and the Cost of Caring for This Population
- Choices for Renal Replacement Therapy
- Clinical Performance Measures For Dialysis
- Chronic Kidney Disease Care and End-Stage Renal Disease Outcomes
- REFERENCES
Topics within this title:
- Abnormalities
- Acidosis
- Acute Renal Failure
- Alkalosis
- Anemia
- Ascites
- Atherosclerosis
- Bacteremia
- Blood pressure
- Cardiovascular Disease
- Chronic Renal Insufficiency
- Coronary Artery Disease
- Coronary Heart Disease
- Diabetes
- duration
- Dyslipidemia
- efficiency
- End-Stage Kidney Disease
- End-Stage Renal Disease
- Endocrine Disease
- Fistula
- Fistulas
- Heart Disease
- Hepatitis
- Hepatitis B
- Hepatitis B virus
- Hepatitis C
- Hypercholesterolemia
- Hyperlipidemias
- Hypertension
- Hypertrophy
- Hypotension
- Hypothyroidism
- Inflammation
- Intoxications
- Kidney Disease
- Left Ventricular Dysfunction
- Left Ventricular Hypertrophy
- loading
- Malnutrition
- Nervous System Abnormalities
- Overdose
- Pain
- Peritonitis
- Poisoning
- Renal Failure
- Renal Insufficiency
- Renal Osteodystrophy
- Respiratory Acidosis
- Respiratory Alkalosis
- Sclerosis
- Seizures
- Stenoses
- Stress
- Thrombosis
- Thyroid Diseases
- Thyrotoxicosis
- Uremia
- Valvular Heart Disease
- Vascular Disease
- Ventricular Dysfunction
- Virus